Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

NCT00114101 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

460

Enrollment

NIH

Sponsor class

Conditions

DS Stage I Multiple Myeloma
DS Stage II Multiple Myeloma
DS Stage III Multiple Myeloma
Refractory Multiple Myeloma
Smoldering Multiple Myeloma

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
DRUG: Melphalan
PROCEDURE: Peripheral Blood Stem Cell Transplantation
OTHER: Placebo Administration

Sponsor

National Cancer Institute (NCI)